Saint-Genis-Pouilly, France, June 22, 2018 - Advanced Accelerator Applications S.A. (AAA), a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback